UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057037
Receipt number R000065190
Scientific Title The effectiveness of web-based psychological education using a cognitive behavioral change approach for workers with anxiety problems: a randomized controlled study
Date of disclosure of the study information 2025/02/14
Last modified on 2025/02/14 16:59:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effectiveness of web-based psychological education using a cognitive behavioral change approach for workers with anxiety problems: a randomized controlled study

Acronym

The effectiveness of web-based psychological education using a cognitive behavioral change approach for workers with anxiety problems: a randomized controlled study

Scientific Title

The effectiveness of web-based psychological education using a cognitive behavioral change approach for workers with anxiety problems: a randomized controlled study

Scientific Title:Acronym

The effectiveness of web-based psychological education using a cognitive behavioral change approach for workers with anxiety problems: a randomized controlled study

Region

Japan


Condition

Condition

Anxiety

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to clarify the effectiveness of web-based psychological education using cognitive behavioral change approaches that can be undertaken by individuals themselves for workers who have anxiety problems but are basically healthy, have not visited a medical institution, and have not been diagnosed with a mental disorder.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Penn State Worry Ques-tionnaire(PSWQ)

Key secondary outcomes

Patient Health Questionnaire-9(PHQ-9)
Generalized Anxiety Disorder-7(GAD-7)
World Health Organization Health and Work Performance Questionnaire(WHO-HPQ9
Minimally Important Difference(MID)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Cognitive behavioral therapy

Interventions/Control_2

Time and weather records

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1)Those aged between 18 and 65
2)Those working at least 20 hours per week
3)Those with symptoms of anxiety that have persisted for two weeks at two-week intervals with a score of 8 or more (Mildillness or higher) on the GAD-7 (Generalized Anxiety Disorder Scale)
(The GAD-7 is assessed twice, with a two-week gap between the first and second assessments, and a score of 8 or more on the GAD-7 is recorded for both assessments)
4)Those who have never visited a psychiatric clinic, psychosomatic clinic, or mental health clinic, and have never been diagnosed with a mental disorder
5)Those who have access to the internet (either a computer, smartphone, or tablet)
6)Those whose native language is Japanese, who can understand explanations in Japanese, and who can give their own free consent online

Key exclusion criteria

1) Those who are currently being treated for a physical or mental illness at a medical institution (including psychiatric, psychosomatic, or mental health clinics)
2) Those who were indicated as requiring a detailed examination or treatment in their most recent health checkup (however, this does not exclude those who were indicated as having no abnormalities, mild abnormalities, or requiring a re-examination or lifestyle improvement)
3) Those who were indicated as being in a high-stress state in their most recent stress checkup, or those who feel that they are in a high-stress state at their current workplace

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Shimizu

Organization

Chiba University

Division name

Graduate School of Medicine Cognitive Behavioral Physiology

Zip code

260-8677

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba

TEL

043-226-2027

Email

neurophys1@ML.chiba-u.jp


Public contact

Name of contact person

1st name Yoichi
Middle name
Last name Seki

Organization

Chiba University

Division name

Research Center for Child Development

Zip code

260-8677

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba

TEL

043-226-2975

Homepage URL


Email

chibarccmd@ML.chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Research Institute of Economy, Trade and Industry

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University Graduate School of Medicine School of Medicine

Address

1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba

Tel

043-222-7171

Email

inohana-kyodo@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 11 Month 21 Day

Date of IRB

2024 Year 11 Month 21 Day

Anticipated trial start date

2025 Year 02 Month 17 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 02 Month 14 Day

Last modified on

2025 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065190